281 related articles for article (PubMed ID: 28455829)
1. A Novel Apremilast Nail Lacquer Formulation for the Treatment of Nail Psoriasis.
Kushwaha AS; Repka MA; Narasimha Murthy S
AAPS PharmSciTech; 2017 Nov; 18(8):2949-2956. PubMed ID: 28455829
[TBL] [Abstract][Full Text] [Related]
2. Optimized Ciclopirox-Based Eudragit RLPO Nail Lacquer: Effect of Endopeptidase Enzyme as Permeation Enhancer on Transungual Drug Delivery and Efficiency Against Onychomycosis.
Khattab A; Shalaby S
AAPS PharmSciTech; 2018 Apr; 19(3):1048-1060. PubMed ID: 29138987
[TBL] [Abstract][Full Text] [Related]
3. Matrix based system of isotretinoin as nail lacquer to enhance transungal delivery across human nail plate.
Joshi M; Sharma V; Pathak K
Int J Pharm; 2015 Jan; 478(1):268-277. PubMed ID: 25445993
[TBL] [Abstract][Full Text] [Related]
4. Development of ciclopirox nail lacquer with enhanced permeation and retention.
Thapa RK; Choi JY; Go TG; Kang MH; Han SD; Jun JH; Son MW; Yong CS; Kim JO
Arch Pharm Res; 2016 Jul; 39(7):953-9. PubMed ID: 27306785
[TBL] [Abstract][Full Text] [Related]
5. Transungual delivery of ketoconazole using novel lacquer formulation.
Hafeez F; Hui X; Chiang A; Hornby S; Maibach H
Int J Pharm; 2013 Nov; 456(2):357-61. PubMed ID: 24029171
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Ungual Permeation of Terbinafine HCl Delivered Through Liposome-Loaded Nail Lacquer Formulation Optimized by QbD Approach.
Shah VH; Jobanputra A
AAPS PharmSciTech; 2018 Jan; 19(1):213-224. PubMed ID: 28681334
[TBL] [Abstract][Full Text] [Related]
7. Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers.
Hafeez F; Hui X; Selner M; Rosenthal B; Maibach H
Drug Dev Ind Pharm; 2014 Jun; 40(6):838-44. PubMed ID: 23600655
[TBL] [Abstract][Full Text] [Related]
8. Trans-ungual Delivery of AR-12, a Novel Antifungal Drug.
Kushwaha AS; Sharma P; Shivakumar HN; Rappleye C; Zukiwski A; Proniuk S; Murthy SN
AAPS PharmSciTech; 2017 Oct; 18(7):2702-2705. PubMed ID: 28289970
[TBL] [Abstract][Full Text] [Related]
9. Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2).
Rich P; Gooderham M; Bachelez H; Goncalves J; Day RM; Chen R; Crowley J
J Am Acad Dermatol; 2016 Jan; 74(1):134-42. PubMed ID: 26549249
[TBL] [Abstract][Full Text] [Related]
10. Formulation development and optimization of transungual drug delivery system of terbinafine hydrochloride for the treatment of onychomycosis.
Patel MM; Vora ZM
Drug Deliv Transl Res; 2016 Jun; 6(3):263-75. PubMed ID: 26926242
[TBL] [Abstract][Full Text] [Related]
11. TranScreen-N: Method for rapid screening of trans-ungual drug delivery enhancers.
Murthy SN; Vaka SR; Sammeta SM; Nair AB
J Pharm Sci; 2009 Nov; 98(11):4264-71. PubMed ID: 19363796
[TBL] [Abstract][Full Text] [Related]
12. Nail swelling as a pre-formulation screen for the selection and optimisation of ungual penetration enhancers.
Khengar RH; Jones SA; Turner RB; Forbes B; Brown MB
Pharm Res; 2007 Dec; 24(12):2207-12. PubMed ID: 17665289
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of apremilast through 104 weeks in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment: findings from the LIBERATE study.
Reich K; Gooderham M; Bewley A; Green L; Soung J; Petric R; Marcsisin J; Cirulli J; Chen R; Piguet V
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):397-402. PubMed ID: 29220542
[TBL] [Abstract][Full Text] [Related]
14. Treatment of nail psoriasis with 8% clobetasol nail lacquer: positive experience in 10 patients.
Sánchez Regaña M; Martín Ezquerra G; Umbert Millet P; Llambí Mateos F
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):573-7. PubMed ID: 16164711
[TBL] [Abstract][Full Text] [Related]
15. Ciclopirox delivery into the human nail plate.
Hui X; Wester RC; Barbadillo S; Lee C; Patel B; Wortzmman M; Gans EH; Maibach HI
J Pharm Sci; 2004 Oct; 93(10):2545-8. PubMed ID: 15349963
[TBL] [Abstract][Full Text] [Related]
16. High failure rate of transungal drug delivery: need for new strategies.
Tiwary AK; Sapra B
Ther Deliv; 2017 Mar; 8(5):239-242. PubMed ID: 28361611
[No Abstract] [Full Text] [Related]
17. Onychopharmacokinetics of terbinafine hydrochloride penetration from a novel topical formulation into the human nail in vitro.
Hui X; Lindahl Å; Lamel S; Maibach HI
Drug Dev Ind Pharm; 2013 Sep; 39(9):1401-7. PubMed ID: 22873754
[TBL] [Abstract][Full Text] [Related]
18. Effective treatment of nail psoriasis with apremilast: report of two cases and review of the literature.
Magdaleno-Tapial J; Valenzuela-Oñate C; Ortiz-Salvador JM; Subiabre-Ferrer D; Hernández-Bel P
Dermatol Online J; 2018 Sep; 24(9):. PubMed ID: 30677839
[TBL] [Abstract][Full Text] [Related]
19. Improvement of Nail and Scalp Psoriasis Using Apremilast in Patients With Chronic Psoriasis: Phase 2b and 3, 52-Week Randomized, Placebo-Controlled Trial Results.
Nguyen CM; Leon A; Danesh M; Beroukhim K; Wu JJ; Koo J
J Drugs Dermatol; 2016 Mar; 15(3):272-6. PubMed ID: 26954311
[TBL] [Abstract][Full Text] [Related]
20. Ciclopirox nail lacquer 8%: in vivo penetration into and through nails and in vitro effect on pig skin.
Ceschin-Roques CG; Hänel H; Pruja-Bougaret SM; Luc J; Vandermander J; Michel G
Skin Pharmacol; 1991; 4(2):89-94. PubMed ID: 1831626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
